אביליפיי 10 מ"ג

Country: Իսրայել

language: եբրայերեն

source: Ministry of Health

active_ingredient:

ARIPIPRAZOLE 10 MG

MAH:

BRISTOL-MYERS SQUIBB (ISRAEL) LIMITED

ATC_code:

N05AX12

pharmaceutical_form:

TABLETS

administration_route:

PER OS

manufactured_by:

BRISTOL-MYERS SQUIBB S.R.L, ITALY

therapeutic_group:

ARIPIPRAZOLE

therapeutic_indication:

Abilify is indicated for the treatment of schizophrenia. And for the treatment of moderate to severe manic episodes in Bipolar I disorder and for the prevention of a new manic episode in patient who experienced predominantly manic episodes and whose manic episodes responded to aripiprazole treatment.

authorization_date:

2010-02-01